Michael Berendt

Chairman at

Anchor Therapeutics, Inc.

77 year

82 connections

Health Technology

Finance

Consumer Services

Profile

Dr. Michael J.
Berendt is an Executive Chairman at Retension Pharmaceuticals, Inc. and an Executive Chairman at Anchor Therapeutics, Inc. Dr. Berendt was previously employed as a Director, Chief Executive & Scientific Officer by Telesta Therapeutics, Inc., a President & Chief Executive Officer by Aegera Therapeutics, Inc., a Managing Director by RCT BioVentures, a Managing Director by Research Corporation Technologies, Inc., a Managing Director by AEA Investors LP, an Independent Director by Waters Corp., a Senior Vice President-Research by Bayer Corp., a Group Director-Drug Discovery by Pfizer Inc., and a Chairman by Alethia Biotherapeutics, Inc. He also served on the board at Trillium Therapeutics, Inc. /Old/, Catalyst Bioscience, Inc. /Old/, Grifols Canada Plasma Resources, Inc., Myriad Genetics, Inc., Neomed Institute, Northstar Neuroscience, Inc. and Onyx Pharmaceuticals, Inc. He received his undergraduate degree from Ohio Dominican University, a graduate degree from Miami University and a doctorate degree from Drexel University.

Michael Berendt active positions

Companies	Position	Start
Anchor Therapeutics, Inc. Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors	Chairman	-

All active positions of Michael Berendt

Former positions of Michael Berendt

Companies	Position	End
WATERS CORPORATION	Director/Board Member	04/10/2021
TELESTA THERAPEUTICS INC	Chief Executive Officer	31/10/2016
Trillium Therapeutics, Inc. /Old/ Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals	Director/Board Member	05/06/2014
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs	Chief Executive Officer	30/06/2011
RCT BioVentures RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm focuses on biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements.	Corporate Officer/Principal	30/11/2005

See the detail of Michael Berendt's experience

Training of Michael Berendt

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Michael Berendt's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	20
Pfizer Inc. Pfizer Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development, manufacturing, marketing, sale and distribution of biopharmaceutical products & ingredients	Health Technology
Waters Corp. Waters Corp. Medical SpecialtiesHealth Technology Designs, manufactures, sells and services analytical technologies: liquid chromatography, mass spectrometry, and thermal analysis	Health Technology
Onyx Pharmaceuticals, Inc. Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer	Health Technology
Myriad Genetics, Inc. Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products	Health Technology
Bayer Corp. Bayer Corp. Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical, healthcare & agricultural products	Health Technology
AEA Investors LP AEA Investors LP Investment ManagersFinance AEA Investors invests in middle-market companies located across the globe primarily in North America with an enterprise value of USD 400 million - 2.5 billion and an EBITDA of USD 5 - 200 million. The firm focuses on industrial & industrial services, tech-enabled business services and tech-enabled healthcare services. It participates in buyout and growth stage transactions in the form of debt and equity with an investment size of USD 50 – 150 million. The firm makes co-investments and acquires majority and minority interests.	Finance
Telesta Therapeutics, Inc. Telesta Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Researches and develops pharmaceutical products for the human and veterinary markets	Health Technology
Northstar Neuroscience, Inc. Northstar Neuroscience, Inc. Medical SpecialtiesHealth Technology Provides solutions for stroke and other neurological diseases and disorders	Health Technology
Catalyst Bioscience, Inc. /Old/ Catalyst Bioscience, Inc. /Old/ Medical SpecialtiesHealth Technology Develops and markets catalytic biopharmaceutical products	Health Technology
Anchor Therapeutics, Inc. Anchor Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Designs and develops peptide modulators of G protein-coupled receptors	Health Technology
RCT BioVentures RCT BioVentures Investment ManagersFinance RCT BioVentures invests in companies located in the United States. The firm focuses on biotechnology, medical devices & technology sectors. It provides financing for early stage capital requirements.	Finance
Drexel University Drexel University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Miami University Miami University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Ohio Dominican University Ohio Dominican University Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs	Health Technology
Trillium Therapeutics, Inc. /Old/ Trillium Therapeutics, Inc. /Old/ Miscellaneous Commercial ServicesCommercial Services Provides research and development of pharmaceuticals	Commercial Services
Alethia Biotherapeutics, Inc. Alethia Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets	Health Technology
Research Corporation Technologies, Inc. Research Corporation Technologies, Inc. Financial ConglomeratesFinance Provides investment related services	Finance
Neomed Institute Neomed Institute Pharmaceuticals: OtherHealth Technology Operates as a non-profit organization for pharmaceutical companies	Health Technology
ProMetic Plasma Resources, Inc. ProMetic Plasma Resources, Inc. Medical/Nursing ServicesHealth Services Operates plasma donation centers	Health Services